Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIRGO: Vuity BID in Presbyopia
NCT04983589Phase 3Completed
- Sponsor
- Allergan
- Start
- Sep 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by Allergan. Started Sep 2021; status: completed.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT04983589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04983589.